GastroFinder® 2Smart

Multiplex qualitative real‑time PCR kit for the syndromic approach to gastrointestinal infections.

Product description

The GastroFinder® 2Smart kit is an advanced qualitative in vitro diagnostic test designed for the rapid diagnosis and syndromic management of gastrointestinal infections. Its high‑throughput multiplex design allows the simultaneous identification of 18 of the most common and clinically relevant gastroenteritis‑causing pathogens (bacteria, parasites, and viruses) in a single reaction.

Its optimised workflow provides results in approximately 2.5 hours after the nucleic acid extraction process. Thanks to high‑resolution melting curve analysis, the platform ensures precise differentiation of microorganisms, facilitating early therapeutic intervention, reduction of nosocomial outbreaks, and effective epidemiological control.

Pathogens detected (18)

The panel simultaneously identifies and differentiates the following 18 pathogenic microorganisms from stool samples:

Bacteria (9)
Campylobacter spp. Salmonella spp. Yersinia enterocolitica Clostridium difficile toxin A Clostridium difficile toxin B Shiga toxin‑producing Escherichia coli (STEC) stx1/stx2 Enteropathogenic Escherichia coli (EPEC) eae Enterotoxigenic Escherichia coli (ETEC) elt/est Shigella / Enteroinvasive Escherichia coli (EIEC) ipaH
Parasites (4)
Entamoeba histolytica Giardia lamblia Cryptosporidium spp. Dientamoeba fragilis
Viruses (5)
Norovirus (GI/GII/GIV) Rotavirus (A) Adenovirus (40/41) Astrovirus Sapovirus (GI/GII/GIV/GV)

Key advantages and features

Comprehensive Syndromic Approach: Detects 18 respiratory and gastrointestinal pathogens in a single analysis, accelerating the screening process compared to traditional culture methods. Maximum Sensitivity: Offers a clinical sensitivity level equivalent to individual singleplex real‑time PCR assays. Results in Record Time: Amplification and detection process completed in just 2.5 hours after extraction. Validated Sample and Extraction: Optimised for stool samples. The nucleic acid extraction method has been validated using the automated NuclisENS® easyMAG® platform (bioMérieux). Complete Quality Control: The kit includes ready‑to‑use Internal Control (IC), Amplification Controls (AC) and Positive Control (PC), ensuring the technical reliability of the assay. Interpretation Software: Digital support with result interpretation software available to facilitate the reading and reporting workflow.
×

Area:

Bacteria, Microbiology, Virus
Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)